Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 48.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity. Therefore, BF% should be considered as a more important indicator of undernutrition in neonates than birth weight percentiles alone. It is possible that both measures may be needed for optimal identification of high-risk infants and targeting interventions. Further studies are required to confirm these findings and to determine whether BF% is a better predictor of adverse outcome than birth weight percentiles or other markers of malnutrition. Increasing BF% could improve health outcomes in neonates and reduce the risk of morbidity. Future studies should investigate the relationship between BF% and other indices of nutritional status and its impact on infant health. This is an important finding given the potential benefits of increasing BF% in neonates at high risk of morbidity. Further research into the relationship between BF% and other indices of nutritional status will help identify opportunities for improving infant health. This study demonstrates the importance of measuring BF% in addition to birth weight percentiles. Additional studies are required to further investigate the association between BF% and neonatal morbidity and to assess the clinical usefulness of this index.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.7
Reasoning:
The assistant’s response correctly identifies that low BF% is associated with increased neonatal morbidity and that BF% appears to be a more informative marker than birth weight percentiles alone. It appropriately suggests that BF% measurement could complement birth weight and that further studies are needed. However, the reply oversteps in implying that “increasing BF% could improve health outcomes” (a causal inference not established by the presented observational data), is somewhat repetitive, and omits specific study findings (effect sizes) that would strengthen the conclusion.

conciseness: 0.3
Reasoning:
The assistant’s answer is correct in concluding that low BF% is more closely associated with neonatal morbidity than birth weight percentiles, but it is not concise: it repeats the same points several times, adds speculative recommendations (e.g., “increasing BF% could improve health outcomes”) without study evidence, and fails to cite the study’s key quantitative findings (odds ratios) that would have supported a succinct comparison. A concise response would state the main conclusion, briefly note the strength of association versus birth weight percentiles, and mention that further research is needed. 

relevance: 0.6
Reasoning:
The assistant's reply is relevant and answers the question: it states that low BF% is associated with higher neonatal morbidity and that BF% should be considered a more important indicator than birth weight percentiles alone, which aligns with the study's findings. However, it does not quote or explicitly cite any exact line from the provided context (it paraphrases), repeats points, and adds speculative claims (e.g., that increasing BF% would improve outcomes) that go beyond the presented data.

coherence: 0.6
Reasoning:
The response is generally coherent and answers the question by stating that low BF% is associated with higher neonatal morbidity and that BF% should be considered alongside (or potentially instead of) birth weight percentiles. It is organized into a clear conclusion and recommendations for further study. However, it is repetitive, makes an unsupported causal claim ("Increasing BF% could improve health outcomes"), and fails to cite or quantify the comparative strength of association reported in the study (e.g., the larger OR for BF%). Overall it communicates the main point but lacks precision and includes speculative language.

helpfulness: 0.6
Reasoning:
The assistant’s reply correctly concludes that low BF% is associated with higher neonatal morbidity and that BF% adds value beyond birth weight percentiles. It is helpful insofar as it recommends using BF% in addition to birth weight and calls for more research. However, the answer has notable weaknesses: it is repetitive, omits key study specifics (effect sizes, how many neonates were identified by BF% vs birth weight), and oversteps the data by implying causation ("Increasing BF% could improve health outcomes") rather than reporting an observational association. It also misses the important point that BF% can identify undernourished infants who are appropriately grown and can exclude small infants not at risk. Overall, the response is useful but imprecise and somewhat overstated.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The data suggest that there might be differences in the management of this condition according to its etiology. This is the first study reporting on the results of combined surgical and orthopedic treatment of ischemic Charcot neuroarthropathy. The fact that the limb salvage rate was so high in our series suggests that in cases of severe ischemic neuropathic ulcers, the early application of an intervention based on vascular reconstruction might be justified. We also found that the time needed to heal the lesion was significantly longer than that reported in other studies. Further investigations are warranted to better understand the natural history of this disease and to identify the best therapeutic approach. The study has some limitations due to its small sample size and retrospective design. Therefore, further studies should be conducted to confirm these results. However, these findings open up new perspectives in the management of ischemic Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.8
Reasoning:
The response is largely correct and on point: it recognizes that ischemic Charcot foot requires different management (vascular assessment and revascularization to support surgical/orthopedic treatment), cites the high limb-salvage rate after combined therapy, and appropriately notes longer healing times and study limitations. It is cautiously worded (uses "might be justified") rather than stating revascularization as mandatory and includes an unverified claim ("first study") — these minor issues prevent a perfect score but do not undermine the core correctness.

conciseness: 0.7
Reasoning:
The assistant’s reply answers the question by asserting that ischemic Charcot neuroarthropathy may require different management (notably early revascularization) and supports this with study outcomes (90% limb salvage, longer healing time) while noting limitations (small, retrospective series). It is generally relevant and evidence-linked but slightly repetitive and could be more direct and specific about treatment recommendations.

relevance: 0.8
Reasoning:
The assistant's reply is relevant to the question: it interprets the presented data as indicating that ischemic Charcot neuroarthropathy may require different management (specifically early vascular reconstruction alongside surgical/orthopedic care) and it refers to study findings (high limb salvage rate; longer healing time; small retrospective series). It therefore answers the question using conclusions supported by the context. Minor issues: it makes a blanket claim ("first study") without explicit support in the excerpt and it could have been stronger by citing the key numeric results (90% limb salvage; mean healing time ~197 days) rather than only qualitative statements.

coherence: 0.8
Reasoning:
The response is coherent and reasonably well organized: it summarizes the study findings, draws a clear clinical implication (that ischemic Charcot may require revascularization-based management), notes longer healing time, and acknowledges study limitations. It could be more direct in answering the posed question (explicitly stating "yes, it is different and often requires different treatment") and could briefly clarify which specific treatment differences are supported by the data. Overall it stays on-topic and logically structured.

helpfulness: 0.7
Reasoning:
The response is concise, appropriately cautious, and addresses the question by asserting that ischemic Charcot neuroarthropathy may require different management—specifically early revascularization in addition to surgical/orthopedic care. It correctly notes the study's favorable limb-salvage outcome, longer healing time, and the limitations (small, retrospective series) and calls for further research. However, it could be more direct in answering "different disease with different treatment?" (a clearer yes/no statement), would be stronger if it cited the study's key numeric results (90% limb salvage; mean healing 197 days), and could give more concrete guidance about how management differs from non-ischemic Charcot foot rather than general statements.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: In this study, we found that radical hysterectomy may be unnecessary in patients with endometrial adenocarcinoma with suspected cervical involvement. Although there was no difference in survival outcomes among patients with different types of surgery, further investigation should be made to determine the appropriate treatment strategy. In addition, the oncologist should consider the risks and benefits of each operation in order to provide optimal care for each patient. We recommend that all patients with endometrial adenocarcinoma with suspected cervical involvement receive surgical treatment, including radical hysterectomy or other less invasive procedures, based on individual clinical situations. Further studies are warranted to confirm our results and to identify a more effective treatment strategy for these patients. This study showed that a radical hysterectomy could be performed safely and effectively, without increasing mortality or morbidity in patients with endometrial cancer. However, it remains unclear whether this procedure provides an additional benefit compared with other operations. Therefore, further evaluation is required to clarify the role of radical hysterectomy in the management of endometrial adenocarcinoma with suspected cervical involvement. Moreover, we could not demonstrate any advantage of radical hysterectomy over mastectomy or other operations. However, the incidence of lymph node metastasis in our series was very low, which might have limited the power of this study to detect such differences. Therefore, we cannot rule out the possibility that there might be a small but statistically significant benefit from radical hysterectomy in patients with high risk of disease recurrence. As a result, we believe that further prospective randomized trials are necessary to establish the optimal treatment strategy for patients with endometrial adenocarcinoma with suspected cervical involvement. We also suggest that patients with endometrial cancer with suspected cervical involvement should be given the opportunity to participate in such trials. Finally, this study suggests that radical hysterectomy should not be considered as standard treatment for patients with endometrial adenocarcinoma with suspected cervical involvement, because of its relatively poor long-term outcome. Thus, we recommend that patients with endometrial cancer with suspected cervical involvement should receive treatment according to their clinical condition. Radical hysterectomy should only be performed if the patient's condition warrants it. Furthermore, it is important to emphasize that the choice of surgical procedure should be individualized, based on each patient's unique clinical situation. If possible, we recommend that all patients with endometrial cancer with suspected cervical involvement be referred to a gynecologic oncology specialist for preoperative counseling and postoperative follow-up. In conclusion, the current evidence does not support the use of radical hysterectomy as standard treatment for patients with endometrial cancer with suspected cervical involvement. Instead, we recommend that patients receive individualized treatment based on their clinical condition. Further studies are needed to confirm these findings and to define the best treatment strategy for these patients.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.3
Reasoning:
Short explanation:
The response contains some correct points (it notes no clear survival benefit of radical hysterectomy and calls for further prospective study and individualized treatment). However it also makes several factual errors and contradictory statements that conflict with the study findings: it claims radical hysterectomy "could be performed safely and effectively, without increasing mortality or morbidity," whereas the study reported higher perioperative and late adverse events (longer operative time, higher transfusion rates, more severe urinary dysfunction) with RH. It also includes irrelevant/incorrect references (mention of "mastectomy") and repeats contradictory recommendations (both that RH is unnecessary and that it is safe/effective), reducing clarity and accuracy. Overall the answer is unreliable and partly incorrect.

conciseness: 0.2
Reasoning:
The assistant's reply is verbose and repetitive, often restating the same points and including irrelevant or contradictory statements (for example, it first says radical hysterectomy (RH) may be unnecessary and shows no survival benefit, then later asserts RH can be performed "safely and effectively without increasing mortality or morbidity," which conflicts with the study's finding of more perioperative and late adverse events with RH). It also contains an irrelevant mention of "mastectomy." It does convey the key idea that RH showed no survival benefit and that further prospective study is needed, but the answer is not concise or consistently accurate.

relevance: 0.3
Reasoning:
The assistant's reply is only partially relevant. It does answer the question by concluding that radical hysterectomy may be unnecessary and advocating individualized treatment and further study, which aligns broadly with the study's main conclusion. However, it fails to cite or quote the provided context and it misrepresents key findings (claims RH "could be performed safely...without increasing morbidity" despite the context reporting more perioperative and late adverse events with RH). The reply also includes irrelevant or erroneous statements (e.g., comparing to "mastectomy") and is repetitive. Because of these inaccuracies and lack of faithful reference to the source text, the response's relevance is low.

coherence: 0.3
Reasoning:
Short explanation:
The response attempts to answer the question but is poorly coherent and poorly organized. It contains repetitive, contradictory statements (e.g., first saying RH may be unnecessary, later saying RH can be performed “safely and effectively,” then calling RH of “relatively poor long-term outcome”), includes an irrelevant term (“mastectomy”), and repeats recommendations multiple times without clear synthesis. It does echo the study’s main point that RH showed no survival benefit and had more adverse events, but the mixed messages and redundancy weaken clarity and reliability.

helpfulness: 0.3
Reasoning:
Explanation: The response is repetitive, sometimes self-contradictory, and contains factual inaccuracies relative to the study summary. It correctly conveys the general conclusion that radical hysterectomy (RH) did not show a clear survival benefit and that further study is needed, and it appropriately recommends individualized decision-making and specialist referral. However, it incorrectly states that RH "could be performed safely and effectively, without increasing mortality or morbidity," contradicting the study finding of longer operative time, higher transfusion rates, and greater urinary dysfunction with RH. It also includes irrelevant and incorrect references (e.g., "mastectomy") and overall is overly long and unfocused rather than providing a concise, accurate summary of the primary results and adverse-event differences.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: In this large cohort of patients undergoing PD, readmissions occurred in one-third of patients, with the majority occurring within the first week after discharge. Although the readmission rate declined during the study period, it remained high. Multivariate analysis identified several independent risk factors for readmissions, including pancreatic fistula, multivisceral resections, prolonged length of initial hospital stay, and ICU admissions. These factors may be amenable to change by adopting new strategies in the preoperative and postoperative management of PD. It seems reasonable to expect that implementing these strategies could reduce readmissions rates. The future efficacy of such strategies should be evaluated prospectively. In addition, further studies are needed to determine whether readmission rates correlate with patient outcomes. As a result, the development of a national readmission policy for PD is warranted. Future efforts should also focus on improving the quality of care provided to PD patients. This might involve developing guidelines for PD care, monitoring compliance with these guidelines, and ensuring that all hospitals have access to appropriate resources and support. Finally, education of surgeons, nurses, and other providers caring for PD patients should include training on how to manage postoperative complications and optimize their recovery. Overall, prevention of readmissions after PD will require a comprehensive approach that involves changes in patient selection, perioperative management, and hospital policies. However, the benefit of reducing readmissions is substantial, given the significant economic burden of hospital readmissions.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The response contains several factual errors and misses the key recommendation from the ground truth. It correctly lists independent risk factors identified by multivariate analysis (pancreatic fistula, multivisceral resection, prolonged initial LOS, and ICU admission), but it incorrectly states the overall readmission frequency and temporal trend and downplays the specific recommendation to focus on early readmissions. Specifically:
- Incorrect: it claims readmissions occurred in "one-third" of patients (actual rate = 15%).
- Incorrect: it states the readmission rate "declined" during the study period (the study found an increase in the second half of the decade: 18.6% vs 12.3%).
- Misleading: it says the "majority" occurred within the first week (the data show 50% occurred within 7 days — exactly half, not a clear majority).
- Omission: it does not emphasize the ground-truth recommendation that further efforts should be centered on preventing early readmissions, which constitute half of all readmissions.

Because of these substantive factual mistakes and the omission of the primary take-home message, the response is of low quality despite some correct elements.

conciseness: 0.3
Reasoning:
Explanation: The response is verbose and repetitive and does not present a tight, to-the-point summary. It wanders into broad recommendations and policy suggestions instead of succinctly stating the key findings and actionable conclusion. A concise answer would have briefly reported the readmission rate and timing, listed the independent predictors (pancreatic fistula and complexity of resection among them), and emphasized focusing prevention on early (≈50% within 7 days) readmissions. 

relevance: 0.6
Reasoning:
Explanation: The assistant addresses the prevention question and cites real factors from the context (pancreatic fistula, multivisceral resection, prolonged initial stay, ICU admission) as targets for intervention, so it is relevant to the prompt. However, it contains factual errors and misstatements of the provided data (e.g., saying readmissions occurred in "one-third" of patients and that the rate "declined" over the study period, whereas the context reports a 15% readmission rate and an increase in the second half of the decade). The recommendations are general and not tightly linked to the specific finding that early readmissions make up half of all readmissions. 

coherence: 0.5
Reasoning:
The response is generally well organized and presents a clear structure: it summarizes findings, cites risk factors, and offers prevention strategies and policy recommendations. However, it contains factual inaccuracies (e.g., misstates the readmission frequency and temporal trend) and some recommendations are generic rather than targeted to the key point in the ground truth about preventing early (≤7 day) readmissions. Overall coherence is moderate but undermined by these errors.

helpfulness: 0.3
Reasoning:
Explanation: The response contains some useful elements (it correctly lists several independent risk factors identified in the study — pancreatic fistula, multivisceral/complex resections, prolonged initial stay, ICU admission — and gives reasonable high-level recommendations about multidisciplinary/perioperative improvements). However it also has important factual errors and omissions that reduce its helpfulness: it incorrectly states the readmission incidence as "one-third" instead of ~15%, wrongly claims the readmission rate declined during the study period (the paper reported an increase in the second half of the decade), and describes a "majority" of readmissions occurring within the first week when the study reported about 50% (not a clear majority). The answer is also fairly generic in proposed interventions and fails to emphasize the study’s specific recommendation to focus on preventing early (≤7 day) readmissions. Overall, the response is partially helpful but contains significant factual inaccuracies and misses the key emphasis on early readmissions.

================================================================================
Average correctness Score: 0.57
Average conciseness Score: 0.45
Average relevance Score: 0.615
Average coherence Score: 0.61
Average helpfulness Score: 0.55
